A recent study indicates that patients who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end traditional diet and exercise regimens.
Research printed in a major health publication shows that while overweight individuals often shed a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing these drugs should be informed of the potential of quick weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a reversion to starting weight in about 18 months.
Comparing Treatments
The research, which reviewed 37 of trials involving thousands of participants, compared the effects of the injectable medications with older methods.
The team point out that individuals who shed pounds through diet and exercise usually have a more gradual weight regain—approximately 100 grams monthly—after stopping.
Understanding the Fast Rebound
Experts propose the mode of action of the jabs explains the amplified weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels far above than normal might result in the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating a significant risk."
A Chronic Condition?
The NHS recommend the jabs for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts argue that, considering the high risk of weight regain, the therapy might need to be long-term.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the chronic character of obesity," akin to managing diseases like hypertension.
User Accounts
Individuals who have discontinued the medication report a intense resurgence of appetite.
"It felt as if a switch activating and you're instantly extremely hungry," said one woman.
This difficulty is exacerbated if users have not established lasting lifestyle or habit changes during therapy.
Significant Interest
Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with interest remaining high.
- Use is greater among females than men.
- The middle-aged age group shows the highest level of interest.
- Many access the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a permanent fix and lasting health benefits relies on combined lifestyle changes.
